Selected research
Market Outlook & Growth Opportunities
Global Alpha-Amylase Market Outlook and Growth Opportunities 2026
Market perspective
The global Alpha-Amylase market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Alpha-Amylase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Alpha-Amylase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Alpha-Amylase is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Alpha-Amylase market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Alpha-Amylase market include Novozymes, Calzyme, Biogreen Technochem, Sigma-Aldrich, Enmex and Biolaxi Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Alpha-Amylase market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Alpha-Amylase and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Alpha-Amylase sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alpha-Amylase market size, projected growth trends, production technologies, key applications, and end-use industries.
Alpha-Amylase Segment by Company
Novozymes
Calzyme
Biogreen Technochem
Sigma-Aldrich
Enmex
Biolaxi Corporation
Alpha-Amylase Segment by Type
Plants
Bacteria
Fungi
Alpha-Amylase Segment by Application
Fruit Ripening
Medical Diagnostics
Flour Improvers
Malt Production
Alpha-Amylase Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Alpha-Amylase status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Alpha-Amylase market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Alpha-Amylase significant trends, drivers, influence factors in global and regions.
6. To analyze Alpha-Amylase competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alpha-Amylase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Alpha-Amylase and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alpha-Amylase.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Alpha-Amylase market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alpha-Amylase industry.
Chapter 3: Detailed analysis of Alpha-Amylase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Alpha-Amylase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Alpha-Amylase in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Plants
- Bacteria
- Fungi
Applications
- Fruit Ripening
- Medical Diagnostics
- Flour Improvers
- Malt Production
Companies covered
- Novozymes
- Calzyme
- Biogreen Technochem
- Sigma-Aldrich
- Enmex
- Biolaxi Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Alpha-Amylase Sales Value (2021-2032)
- 1.2.2 Global Alpha-Amylase Sales Volume (2021-2032)
- 1.2.3 Global Alpha-Amylase Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Alpha-Amylase Market Dynamics
- 2.1 Alpha-Amylase Industry Trends
- 2.2 Alpha-Amylase Industry Drivers
- 2.3 Alpha-Amylase Industry Opportunities and Challenges
- 2.4 Alpha-Amylase Industry Restraints
3 Alpha-Amylase Market by Company
- 3.1 Global Alpha-Amylase Company Revenue Ranking in 2025
- 3.2 Global Alpha-Amylase Revenue by Company (2021-2026)
- 3.3 Global Alpha-Amylase Sales Volume by Company (2021-2026)
- 3.4 Global Alpha-Amylase Average Price by Company (2021-2026)
- 3.5 Global Alpha-Amylase Company Ranking (2024-2026)
- 3.6 Global Alpha-Amylase Company Manufacturing Base and Headquarters
- 3.7 Global Alpha-Amylase Company Product Type and Application
- 3.8 Global Alpha-Amylase Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Alpha-Amylase Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Alpha-Amylase Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Alpha-Amylase Market by Type
- 4.1 Alpha-Amylase Type Introduction
- 4.1.1 Plants
- 4.1.2 Bacteria
- 4.1.3 Fungi
- 4.2 Global Alpha-Amylase Sales Volume by Type
- 4.2.1 Global Alpha-Amylase Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Alpha-Amylase Sales Volume by Type (2021-2032)
- 4.2.3 Global Alpha-Amylase Sales Volume Share by Type (2021-2032)
- 4.3 Global Alpha-Amylase Sales Value by Type
- 4.3.1 Global Alpha-Amylase Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Alpha-Amylase Sales Value by Type (2021-2032)
- 4.3.3 Global Alpha-Amylase Sales Value Share by Type (2021-2032)
5 Alpha-Amylase Market by Application
- 5.1 Alpha-Amylase Application Introduction
- 5.1.1 Fruit Ripening
- 5.1.2 Medical Diagnostics
- 5.1.3 Flour Improvers
- 5.1.4 Malt Production
- 5.2 Global Alpha-Amylase Sales Volume by Application
- 5.2.1 Global Alpha-Amylase Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Alpha-Amylase Sales Volume by Application (2021-2032)
- 5.2.3 Global Alpha-Amylase Sales Volume Share by Application (2021-2032)
- 5.3 Global Alpha-Amylase Sales Value by Application
- 5.3.1 Global Alpha-Amylase Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Alpha-Amylase Sales Value by Application (2021-2032)
- 5.3.3 Global Alpha-Amylase Sales Value Share by Application (2021-2032)
6 Alpha-Amylase Regional Sales and Value Analysis
- 6.1 Global Alpha-Amylase Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Alpha-Amylase Sales by Region (2021-2032)
- 6.2.1 Global Alpha-Amylase Sales by Region: 2021-2026
- 6.2.2 Global Alpha-Amylase Sales by Region (2027-2032)
- 6.3 Global Alpha-Amylase Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Alpha-Amylase Sales Value by Region (2021-2032)
- 6.4.1 Global Alpha-Amylase Sales Value by Region: 2021-2026
- 6.4.2 Global Alpha-Amylase Sales Value by Region (2027-2032)
- 6.5 Global Alpha-Amylase Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Alpha-Amylase Sales Value (2021-2032)
- 6.6.2 North America Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Alpha-Amylase Sales Value (2021-2032)
- 6.7.2 Europe Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Alpha-Amylase Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Alpha-Amylase Sales Value (2021-2032)
- 6.9.2 South America Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Alpha-Amylase Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Alpha-Amylase Sales Value Share by Country, 2025 VS 2032
7 Alpha-Amylase Country-level Sales and Value Analysis
- 7.1 Global Alpha-Amylase Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Alpha-Amylase Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Alpha-Amylase Sales by Country (2021-2032)
- 7.3.1 Global Alpha-Amylase Sales by Country (2021-2026)
- 7.3.2 Global Alpha-Amylase Sales by Country (2027-2032)
- 7.4 Global Alpha-Amylase Sales Value by Country (2021-2032)
- 7.4.1 Global Alpha-Amylase Sales Value by Country (2021-2026)
- 7.4.2 Global Alpha-Amylase Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.9.2 France Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.16.2 China Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.19.2 India Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Alpha-Amylase Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Alpha-Amylase Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Alpha-Amylase Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Novozymes
- 8.1.1 Novozymes Company Information
- 8.1.2 Novozymes Business Overview
- 8.1.3 Novozymes Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Novozymes Alpha-Amylase Product Portfolio
- 8.1.5 Novozymes Recent Developments
- 8.2 Calzyme
- 8.2.1 Calzyme Company Information
- 8.2.2 Calzyme Business Overview
- 8.2.3 Calzyme Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
- 8.2.4 Calzyme Alpha-Amylase Product Portfolio
- 8.2.5 Calzyme Recent Developments
- 8.3 Biogreen Technochem
- 8.3.1 Biogreen Technochem Company Information
- 8.3.2 Biogreen Technochem Business Overview
- 8.3.3 Biogreen Technochem Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Biogreen Technochem Alpha-Amylase Product Portfolio
- 8.3.5 Biogreen Technochem Recent Developments
- 8.4 Sigma-Aldrich
- 8.4.1 Sigma-Aldrich Company Information
- 8.4.2 Sigma-Aldrich Business Overview
- 8.4.3 Sigma-Aldrich Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Sigma-Aldrich Alpha-Amylase Product Portfolio
- 8.4.5 Sigma-Aldrich Recent Developments
- 8.5 Enmex
- 8.5.1 Enmex Company Information
- 8.5.2 Enmex Business Overview
- 8.5.3 Enmex Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
- 8.5.4 Enmex Alpha-Amylase Product Portfolio
- 8.5.5 Enmex Recent Developments
- 8.6 Biolaxi Corporation
- 8.6.1 Biolaxi Corporation Company Information
- 8.6.2 Biolaxi Corporation Business Overview
- 8.6.3 Biolaxi Corporation Alpha-Amylase Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Biolaxi Corporation Alpha-Amylase Product Portfolio
- 8.6.5 Biolaxi Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Alpha-Amylase Value Chain Analysis
- 9.1.1 Alpha-Amylase Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Alpha-Amylase Sales Mode & Process
- 9.2 Alpha-Amylase Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Alpha-Amylase Distributors
- 9.2.3 Alpha-Amylase Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst